Clinical Trials Browser

Adjuvants, Immunologic × Gastrointestinal × 90 days × Clear all

NCT06130826 2026-06-03

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Suspended

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms